Arbutus Biopharma Corp. (ABUS)
4.53
-0.17
(-3.62%)
USD |
NASDAQ |
Mar 06, 16:00
4.49
-0.04
(-0.88%)
After-Hours: 20:00
Arbutus Biopharma Free Cash Flow : -44.78M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Moderna, Inc. | -2.075B |
| Merck & Co., Inc. | 12.36B |
| Pfizer Inc. | 9.076B |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.840M |
| Cash from Investing (Quarterly) | -10.23M |
| Cash from Financing (Quarterly) | 0.8496M |
| Free Cash Flow Per Share (Quarterly) | -0.0305 |
| Free Cash Flow to Equity (Quarterly) | -5.447M |
| Free Cash Flow to Firm (Quarterly) | -5.817M |
| Free Cash Flow Yield | -5.17% |